Stocks · Health care · Biological Products, (No Diagnostic Substances)

CG Oncology, Inc.

CGON Clue Score59

United States Fiscal year ends December CIK 0001991792 Results filed 6 Nov 2026

Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

2

Insider

Date

Role

Action

Shares

Price

Amount

Leonard E Post

15 Oct 2026

Director

Sold after exercise

500

$62.48

$31.24K

Leonard E Post

15 Oct 2026

Director

Sold after exercise

500

$61.65

$30.83K

What was left out

Form 4 filings counted 2

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 2

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 1,000

History held since 26 Jan 2024